This new class of antivirals could unlock treatment for viruses beyond just dengue that have been challenging to treat in the past.
Keeping HIV at bay without antiviral drugs
A rare group of patients have been found to maintain a very low viral load and a functional immune system after stopping antiviral treatment.
Using nanomaterials as antivirals in the fight against COVID-19
Scientists are investigating how fullerene nanomaterials can be used as antivirals against different variants of SARS-CoV-2 and other viruses.
Broad-spectrum antivirals made from polymers
Polymer-based broad spectrum antivirals show activity against Zika, Ebola, HIV-1, the Herpes simplex virus, and now, SARS-CoV-2.
New Pfizer and Merck antivirals look hopeful
With SARS-CoV-2 continuing to circulate, new oral antivirals promise to be game changers in helping to end the pandemic.
Why are antiviral drugs for COVID-19 difficult to find?
Viruses are so varied and evolve so quickly that creating effective treatments against them becomes a daunting task.
New macrocycle antiviral drugs show promise in treating influenza
Creating antiviral drugs to help treat infected patients is more important than ever. Now, researchers report a non-toxic macrocycle antiviral agent that shows high efficacy against several influenza strains.
Antiviral Molecules Inspired by Sea Gods and Mermaids
Inactivating viruses from biopharmaceutical source materials can be achieved with detergents. However, the frequently used detergent Triton X-100 is ecotoxic and must be replaced with eco-friendly alternatives.
Influenza Antiviral Agent Regulates ROS
Polymeric nanoparticles acting as intracellular ROS regulators show promise as antiviral agents in influenza-infected kidney cells.
Scientists uncover a hepatitis C drug’s hidden structures
The active structure of an oral macrocyclic drug has eluded scientists for years despite its widespread clinical use—that is, until now.